TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
FRA:NKB2 (USA)   Ordinary Shares
€ 42 +0.30 (+0.72%) Aug 18
18.34
P/B:
12.74
Market Cap:
€ 6.64B ($ 7.69B)
Enterprise V:
€ 6.82B ($ 7.90B)
Volume:
0
Avg Vol (2M):
192.00
Trade In:

TG Therapeutics Inc Valuation Measures